Last edited by Yolmaran
Wednesday, November 11, 2020 | History

3 edition of Guidance on the use of coronary artery stents found in the catalog.

Guidance on the use of coronary artery stents

National Institute for Clinical Excellence.

Guidance on the use of coronary artery stents

  • 32 Want to read
  • 7 Currently reading

Published by National Institute for Clinical Excellence in London .
Written in English

    Subjects:
  • Stents (Surgery),
  • Coronary heart disease -- Treatment.

  • Edition Notes

    StatementNational Institute for Clinical Excellence.
    SeriesTechnology appraisal -- 71
    The Physical Object
    Pagination28 p. ;
    Number of Pages28
    ID Numbers
    Open LibraryOL16005046M
    ISBN 101842574132
    OCLC/WorldCa56540803


Share this book
You might also like
Repetitions and variations in the Fourth Gospel

Repetitions and variations in the Fourth Gospel

GCSE French Homework File

GCSE French Homework File

The 2000 Import and Export Market for Cork and Wood in The Middle East (World Trade Report)

The 2000 Import and Export Market for Cork and Wood in The Middle East (World Trade Report)

Facility Location

Facility Location

Rose Bunnys teatime

Rose Bunnys teatime

Ideologies and the perspective of social change in India

Ideologies and the perspective of social change in India

Jewish frontier anthology, 1945-1967.

Jewish frontier anthology, 1945-1967.

darkness under the earth.

darkness under the earth.

church and the worker.

church and the worker.

Guidance on the use of coronary artery stents by National Institute for Clinical Excellence. Download PDF EPUB FB2

This guidance replaces TA4 'Ischaemic heart disease coronary artery stents' (NICE technology appraisal 4).

Sections of this guidance have been replaced by 'Coronary artery disease – drug-eluting stents' (NICE technology appraisal ). Stents should be used routinely where percutaneous coronary intervention.

There has been rapid evolution of treatment in the Guidance on the use of coronary artery stents book of coronary artery stents, including the development of drug-eluting stents (DES).

The rapid developments in stenting in the treatment of coronary artery disease (CAD) have made it necessary to re-examine the available research evidence to inform national by:   Sections of this guidance have been replaced by 'Coronary artery disease – drug-eluting stents' (NICE technology appraisal ).

Stents should be used routinely where percutaneous coronary intervention (PCI) is the clinically appropriate procedure for patients with either stable or unstable angina or with acute myocardial. 2 Clinical need and practice. CAD is by far the most common cause of heart disease, resulting from the narrowing of coronary arteries ('stenosis') caused by deposition of atherosclerotic plaque.

Coronary artery stenosis may be asymptomatic or may lead to angina, a chest pain that may be severe enough to restrict or prevent exertion.

Evidence-based recommendations on using coronary artery stents. Is this guidance up to date. We reviewed the evidence in October and we are updating this guidance.

Guidance development process. How we develop NICE technology appraisal guidance. This guidance has been partially updated by NICE technology appraisal guidance   So, how best to manage patients with stable coronary artery disease.

A safe and effective long-term strategy for most is to start with medications and healthy lifestyle. For those who continue to be limited by angina, an invasive procedure is appropriate for symptom control. Stents relieve angina, but they do not prevent heart attacks or death.

Coronary artery stent placement, Coronary angioplasty and stenting, Percutaneous coronary interventions, Cardiac cathet erization, Intensive care, Coronary angiography, Heart attack, Cardiogenic shock, Acute coronary syndrome. Show more areas of focus for Malcolm R. Bell, M.D.

Coronary stents are small, wire, mesh tubes that help widen a clogged artery and restore adequate blood flow to the heart. During the procedure, your cardiologist will place the stent over a thin, long tube with a balloon tip called a catheter and insert it into an artery in your groin or arm.

PCI with BMS versus PCI (without stents) Fifty randomised controlled trials (RCTs) were analysed comparing the use of PCI with BMS versus PCI without stents. Because of differences in, and completeness of, the reporting of these trials, the number of trials on which meta-analyses are based is a subset of these 50 trials.

REBEL™ Platinum Chromium Coronary Stent System. The REBEL Stent System is the newest advance in bare-metal stent technology. REBEL Stent has the visibility you want from its PtCr alloy, the strength you need with the lowest recoil* and greatest radial strength †, and the outstanding deliverability you expect from the Boston Scientific family of stents.

The PK Papyrus Stent System is a balloon-expandable covered coronary stent and delivery system. The device is advanced into the perforated coronary artery vessel using a balloon catheter, similar.

The guidance represents the views of the institute's appraisal committee. The institute expects health professionals to take it fully into account when exercising their clinical judgment about the circumstances in which it is appropriate to use coronary artery stents in treating coronary artery disease.

This guidance document provides recommendations for premarket notification ((k)) submissions for guidewires intended for use in the coronary vasculature, peripheral vasculature, and. Cardiovascular Medicine: Coronary Artery Disease will offer today's most up-to-date, user-friendly guidance on the evaluation, diagnosis, and medical and surgical treatment of this most important aspect of cardiovascular disease and will be on the wish list for every trainee and practicising cardiologist, cardiac surgeon, vascular surgeon, diabetologist, cardiac radiologist and any physician.

Drug-eluting stents (DES), coronary artery bypass graft (CABG) surgery, and vascular brachytherapy are conventional therapies of restenosis. Among them, DES has been widely used to treat ISR in clinical by encapsulating antiproliferative drugs (such as paclitaxel, PTX) within a polymer coating on the surface of a metal stent [8].

Objectives This study sought to explore if intravascular ultrasound (IVUS) use in real-world patients is associated with improved long-term outcomes of percutaneous coronary intervention (PCI).

Background The benefit of IVUS use with PCI in real world is uncertain. Methods We identified Medicare patients who underwent PCI from to and evaluated the association of IVUS use with long.

Coronary Artery Stenting is contraindicated for use in: * Patients who can not receive recommended anti-platelet and/or anticoagulant therapy.

* Patients judged to have a lesion that prevents complete inflation of an angioplasty balloon or proper placement of the stent or delivery device.

18 develop, or to submit to FDA, a marketing application for a coronary drug eluting stent (DES). The 19 guidance discusses the data and clinical studies needed to support such an application. Insights from the MAIN-COMPARE (Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis) registry by Park et al.

in a cohort of patients with LM disease who were treated by using either IVUS-guidance (n = ) or conventional angiography (n = ), showed that IVUS-guidance lead to reduction of long-term. Periprocedural intravascular ultrasonography guidance for left main coronary artery stenting is well established.

However, the role of this tool is also important at follow-up interventions. We present a case of a patient with previous history of left main coronary artery angioplasty. Coronary artery stent. When placing a coronary artery stent, your doctor will find a blockage in your heart's arteries (A).

A balloon on the tip of the catheter is inflated to widen the blocked artery, and a metal mesh stent is placed (B). After the stent is placed, the artery is held open by the stent, which allows blood to flow through the.

Sensitivity analyses comparing outcomes with and without IVUS in stable coronary artery disease and acute coronary syndrome, PCI with bare-metal stents and drug-eluting stents, complex and noncomplex PCI, and facilities with 1% to 5%, 5% to 10%, and >10% IVUS use were performed.

Objective: To investigate the relative importance of stent induced arterial stretch and deep injury to the development of in-stent neointima. Setting: Normal porcine coronary arteries Methods: 30 BiodivYsio stents (Biocompatibles) were deployed at a stent to artery ratio of (a moderate injury) and harvested at 28 days.

Multiple serial cross sections were analysed morphometrically and. symptomatic coronary artery disease were rand omly assigned to receive two different kind of stents in both design and strut thicknes s: the thin-strut ACS RX Multilink stent with. Percutaneous coronary intervention (PCI) with implantation of drug-eluting or bare-metal stents has become one of the most frequently performed therapeutic procedures in medicine.

This study sought to explore if intravascular ultrasound (IVUS) use in real-world patients is associated with improved long-term outcomes of percutane. Objectives: The authors sought to explore the comparative clinical efficacy of different imaging modalities for guiding percutaneous coronary interventions (PCI).

Background: Coronary angiography (CA) is the standard imaging modality for intraprocedural guidance of PCI. Intracoronary imaging techniques, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), can. Stent placement is an effective treatment for atherosclerosis, but is suffered from in-stent restenosis (ISR) caused by stent mechanical damage.

Conventional ISR treatment such as drug-eluting stents (DES) is challenged by the low therapeutic efficacy and severe complications, unchangeable drug dosage for individuals, and limited drug. The risk of myocardial infarction or target vessel revascularization was not associated with the use of IVUS guidance.

CONCLUSIONS: Elective stenting with IVUS guidance, especially in the placement of drug-eluting stent, may reduce the long-term mortality rate for unprotected left main coronary artery stenosis when compared with conventional.

After a coronary artery stent is implanted, re-narrowing of the artery may occur. The drug, Ridaforolimus, is released over time from the EluNIR stent surface into the artery wall to help prevent.

The control group was composed of 77 patients treated with BMS during the preceding two years. In the SES group, for complete lesion coverage, stent positioning was intentionally extended into the distal left main coronary artery (LMCA) in 23 patients (34%) with intermediate LMCA narrowing.

Based on these trials, the Taxus stent was approved for use in Europe in [citation needed] With further study, the FDA approved the use of the Taxus stent in the United States in March By the end ofdrug-eluting stents were used in nearly 80 percent of all percutaneous coronary.

Overview. Stenting is now a common procedure for the treatment of coronary artery disease. More than 2 million people get a stent each year. Medtronic has been an innovator and leader in developing bare-metal (BMS) and drug-eluting stents (DES).

Make optimal use of the latest coronary stenting techniques and adjunctive devices with well-rounded guidance from Coronary Stenting, a companion volume to Dr. Topol s Textbook of Interventional Cardiology.

This comprehensive, up-to-date interventional cardiology book keeps you abreast of the latest trial data on efficacy and safety as well as cutting-edge clinical applications in coronary.

For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the Guidelines see https://. During angioplasty, the doctor inserts a tiny balloon at the site of the blockage and expands it, which widens the narrowed artery.

In most cases, a small metal coil called a stent is placed in the clogged artery to help keep the artery open and reduce the risk of it narrowing again. Newer treatment strategies, such as percutaneous coronary intervention with second-generation drug-eluting stents, use of fractional flow reserve guidance, or hybrid revascularization combining minimally invasive coronary artery bypass grafting with percutaneous coronary intervention, may result in further improvements in outcomes in patients.

"Both cardiac surgery and stenting have roles among patients with coronary artery disease," said Dr. Mulukutla. "Because of this, it is important to deliberate carefully with the help of.

A stent is a small tube that doctors can place in a blocked artery to help restore healthy blood flow. In this article, learn more about the procedure, possible risks, and what to expect. Bangalore S, Toklu B, Amoroso N, et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment.

The guidance represents the views of the institute's appraisal committee. The institute expects health professionals to take it fully into account when exercising their clinical judgment about the circumstances in which it is appropriate to use coronary artery stents in treating coronary artery .Stable coronary artery disease and angina can cause disabling symptoms including shortness of breath, pressure or discomfort in the chest, exercise intolerance, and fatigue.

Physicians commonly treat coronary artery disease and angina using invasive procedures such as angioplasty/stents and coronary artery bypass grafting.Objectives: This study sought to determine whether intravascular ultrasound (IVUS) guidance compared with angiographic guidance reduces long-term risk of cardiac death in patients undergoing complex percutaneous coronary intervention (PCI).

Background: Although IVUS is a useful tool for accurate assessment of lesion profiles and optimal stent implantation, there are limited data on long-term.